The likelihood of this condition developing varies widely from less than 1/10,000 to 1/100, as many other factors need to be considered, such as the type, dose and frequency of intake of drug, how long it has been taken for, and why it has been taken. In patients taking drugs for cancer, the likelihood of MRONJ development varies from 0 - 12%. This again, varies with the type of cancer, although prostate cancer and multiple myeloma are reported to be at a higher risk. In patients taking oral drugs for osteoporosis, the likelihood of MRONJ development varies from 0 - 0.2%.
Medication-related osteonecrosis of the jaw
Osteomyelitis
Metastatic tumor of jaws
Osteoradionecrosis
Osteonecrosis of the jaw
Dysbaric osteonecrosis
Alveolar osteitis
Osteochondritis dissecans